PBK
PBK (PDZ binding kinase, also known as TOPK, SPK, Nori-3 and CT84) is a serine/threonine protein kinase that phosphorylates the MAP kinase p38 and appears to be active only in mitosis. It is related to the MAP kinase kinase family. Browse Assay Genie's current range of PBK research reagents below, or read on for the biology behind the target.
PBK is a serine/threonine protein kinase that phosphorylates the MAP kinase p38. UniProt annotates it as seemingly active only in mitosis, and the NCBI Gene summary notes that mitotic phosphorylation is required for its catalytic activity. When phosphorylated, PBK forms a complex with TP53, which leads to TP53 destabilisation and attenuation of the G2/M checkpoint during doxorubicin-induced DNA damage. It may also play a role in the activation of lymphoid cells.
The PBK gene encodes a kinase related to the dual specificity mitogen-activated protein kinase kinase (MAPKK) family. It belongs to the protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase subfamily, and HGNC places it in the PDZ binding kinase family. Alternative splicing of the gene results in multiple transcript variants. The mouse ortholog is Pbk. The encoded protein has been described under several names, including lymphokine-activated killer T-cell-originated protein kinase (the UniProt recommended name), TOPK, SPK, Nori-3 and CT84.
In terms of disease and physiology, overexpression of the PBK gene has been implicated in tumorigenesis. The protein may also support testicular functions, with a suggested role in spermatogenesis. Together with its mitotic activity and its effect on TP53 signalling, these features make PBK a frequent subject in cell cycle and cancer biology research, including work using a PBK antibody or PBK ELISA kit to study its levels.
PBK appears to be active only in mitosis, and mitotic phosphorylation is required for its catalytic activity.
Overexpression of PBK has been implicated in tumorigenesis, making it a target of interest in tumour research.
Phosphorylated PBK forms a complex with TP53, destabilising it and attenuating the G2/M checkpoint after doxorubicin-induced DNA damage.
PBK phosphorylates p38 MAP kinase and may contribute to the activation of lymphoid cells.
PBK is a serine/threonine kinase that phosphorylates the MAP kinase p38 and seems to be active only in mitosis. When phosphorylated, it forms a complex with TP53, leading to TP53 destabilisation and weakening of the G2/M checkpoint after doxorubicin-induced DNA damage.
PBK stands for PDZ binding kinase. Aliases include TOPK, SPK, Nori-3, CT84 and FLJ14385. UniProt lists the protein as lymphokine-activated killer T-cell-originated protein kinase. Alternative splicing of the gene produces multiple transcript variants.
Overexpression of the PBK gene has been implicated in tumorigenesis, and a role in spermatogenesis has been suggested. A mouse ortholog, Pbk, exists. Check the datasheet of any product for its validated reactivity.
Other MAP kinase pathway components, cell cycle regulators and tumour suppressors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96KB5; product specifications from Assay Genie datasheets.